NCT04920526View on ClinicalTrials.gov

Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls

UnknownOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
HPV-Related Carcinoma
Interventions
DRUG

Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine

No intervention will be administered

Sponsors
All Listed Sponsors
collaborator

University of Washington

OTHER

lead

Kenya Medical Research Institute

OTHER